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Abstract
Background: The design of a randomized multicenter trial is presented on the effectiveness of a
prolonged conservative treatment strategy compared with surgery in patients with persisting
intense sciatica (lumbosacral radicular syndrome).
Methods/design:  Patients presenting themselves to their general practitioner with disabling
sciatica lasting less than twelve weeks are referred to the neurology outpatient department of one
of the participating hospitals. After confirmation of the diagnosis and surgical indication MRI
scanning is performed. If a distinct disc herniation is discerned which in addition covers the clinically
expected site the patient is eligible for randomization. Depending on the outcome of the
randomization scheme the patient will either be submitted to prolonged conservative care or
surgery. Surgery will be carried out according to the guidelines and between six and twelve weeks
after onset of complaints. The experimental therapy consists of a prolonged conservative
treatment under supervision of the general practitioner, which may be followed by surgical
intervention in case of persisting or progressive disability. The main primary outcome measure is
the disease specific disability of daily functioning. Other primary outcome measures are perceived
recovery and intensity of legpain. Secondary outcome measures encompass severity of complaints,
quality of life, medical consumption, absenteeism, costs and preference. The main research
question will be answered at 12 months after randomization. The total follow-up period covers two
years.
Discussion: Evidence is lacking concerning the optimal treatment of lumbar disc induced sciatica.
This pragmatic randomized trial, focusses on the 'timing' of intervention, and will contribute to the
decision of the general practictioner and neurologist, regarding referral of patients for surgery.
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Background
One of the greatest advantages of publishing the design of
a randomized controlled trial (RCT) before results are
available is the accessibility to criticism of the methodo-
logical quality irrespective of the results. Firstly the scien-
tific reader must be enabled to search for epidemiological
shortcomings when the results differ from the expected
outcome as compared to results in line with one's expec-
tations. Secondly, it is possible to more extensively elabo-
rate the background and rationale of the research
question, the study population, the chosen treatments
and outcome measures, as compared to publications
describing the trial results. Thirdly, but not less important,
publishing the design of a RCT is instrumented in prevent-
ing publication bias in subsequent meta-analyses. Studies
with non-significant results are less likely to be published
than those with significant results [1,2]. It is a considera-
ble loss for data pooling that unpublished trial results are
omitted. After pre-publishing the study design even
unpublished data can be used in a systematic review, since
these can be required from the study group. This article
describes the rationale and parallel group design of a RCT
in which the optimal timing of disc surgery for sciatica
will be investigated.
The lumbosacral radicular syndrome (LSRS or LRS; also
called sciatica) is typically characterized by radiating pain
in the dermatome of a lumbar or sacral spinal nerve root.
Occasionally more than one root is involved. Contained
in the syndrome pain may be accompanied with lumbar
fixation, reflex abnormalities motor and sensory distur-
bances. In diagnosis includes stenosis of the spinal and/or
root canal, infection, multiple sclerosis, autoimmune or
metabolic neuropathy, and tumour. This study will be
restricted to herniations at the lowest three lumbar disc
levels, since these represent the most common sites. In the
vast majority of cases LSRS is the result of a herniated disc.
In the Netherlands annually between 60,000 and 75,000
new cases of LSRS are diagnosed by the General Practi-
tioner (GP) [3]. The presumed direct medical costs of
treatment of LSRS are € 133 million each year [4]. Most of
these costs are attributable to in-hospital treatment; only
a small portion is incurred by GP's or physiotherapists (€
3.2 million). In a study, performed in 1988, more than
11.000 patients were operated in the Netherlands and this
frequency did not change in the past years [4,5]. The com-
bined direct and indirect costs are estimated to be € 1,2
billion per year [6]. The indirect costs are considerable due
to the high rate of production loss caused by sciatica.
The natural history of LSRS is in general favourable. In
60–80 percent of patients, the leg pain decreased or disap-
peared within 6–12 weeks after onset [7-9,51]. These
patients no longer experienced problems at work or in
their private lives after three months. The minority with
lasting complaints beyond three months further decreases
with time. At one year only a small proportion of herni-
ated discs continues to produce discomfort and disability.
At present it is not possible to identify these latter groups
of patients in an early stage of their disease by means of
intensity of pain, neurological deficit, root irritation signs,
or diagnostic imaging. For this reason it is not helpful to
perform early diagnostic imaging (CT or MRI), unless a
disease entity different from disc herniation is considered.
After the indication for surgery has been set diagnostic
imaging is helpful in defining the exact site of disc herni-
ation and its anatomical relationship with the nerve root
involved.
Since the first publication on lumbar disc surgery by Mix-
ter and Barr [17] many studies have demonstrated the suc-
cess of surgery for the treatment of LSRS. Unfortunately
only a few prospective studies investigated the difference
in outcome between surgical and conservative care
[7,8,18-22]. The published treatment results vary as much
as the frequency of reported complications and the recur-
rence rate.
The only study, which compared surgery with conserva-
tive care directly in a RCT, was performed by Weber more
than 20 years ago [7,8]. He found better results for surgery
at one-year follow-up. At four and ten years follow-up the
results of surgical and conservative care no longer differed.
Being the only published RCT comparing surgical and
conservative care, this study regrettably carries some
important methodological flaws in both design and out-
come measures when compared to today's epidemiologi-
cal standard rules [23]. One of the main shortcomings is
the exclusion of patients, who do have an indication for
surgery because of "intolerable" pain. Those are the cur-
rent patients who ask for surgery and are not comparable
to the randomized population of Weber. Therefore it is
impossible to extrapolate and generalize these results to
the treatment policy of today.
Since 1983 a few cohort studies have been published on
non-surgical treatment of patients with at least six weeks
of leg pain with good short-term results at one-year fol-
low-up [25,22]. These studies also suffer from methodo-
logical flaws. The only conclusion that can be drawn from
these reports and the study of Weber is that the policy of
prolonged conservative care can be effective, as a result of
the favourable natural course of LSRS. Epidemiological
and clinical studies have shown that most lumbar disc
protrusions resolve spontaneously with the elapse of time
[15,16]. Another finding is that prolonged conservative
care appears safe and without complications if the patient
remains active. Recent population based studies however
state that the natural history is not favourable at all [50].BMC Musculoskeletal Disorders 2005, 6:8 http://www.biomedcentral.com/1471-2474/6/8
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Whether particular demographic findings, symptoms,
physical signs and/or MRI findings either separately or
combined do have prognostic value has not been investi-
gated scientifically yet. It would be of great value if one
were able to identify early in the course of the disease
those patients who will have an unfavourable outcome
without surgery.
In spite of the known favourable natural course the surgi-
cal rate in the Netherlands is quite high [10]. We perform
six times as many lumbar discectomies compared to Scot-
land, four times the number in England and two times the
number in Sweden. In the latter study comparing 12 West-
ern countries the United States is the only country where
more operations are performed for the indication LSRS.
There are no substantial differences in the incidence of
this disease in the countries mentioned that can explain
the difference in surgical rates. There is no indication [6]
that the surgical rate has changed under influence of the
consensus reports [11,12,11]. Actually change was not
likely to occur because the published guidelines were rep-
resentative for daily practice and normal care before 1996
in the Netherlands. With respect to the indications for and
timing of surgery no evidence in the literature is available
to either support or contradict these guidelines. These
guidelines were produced after agreement between all
medical (sub-) disciplines involved in the care for patients
with LSRS. Our high surgical rate, as contradictory as it
may seem, may reflect good clinical practice.
Because of the observation that most people recover from
their complaints in the first 6–8 weeks [9,51] this period
of persistent radicular leg pain is considered a good indi-
cation for surgery in the Netherlands. Although there is
consensus that surgery is only offered in case of persistent
pain, the timing of this treatment seems to depend on
local production capacity and patient and doctor prefer-
ences rather than on evidence-based practice. This lack of
evidence for the timing of surgery after the 6–8 week
period explains the large variations in daily practice. Exact
data on the problems associated with surgery, such as sur-
gical failure, recurrent disc herniation and adverse effects
are limited. This is one of the reasons that in some regions
surgery will only be carried out after a period of 3–6
months of LSRS. [14].
It is not known whether the relative high rate of disc sur-
gery in the Netherlands is cost-effective or not, compared
to other countries [15,16].
In summary, consensus is missing on the preferred timing
of disc surgery, due to insufficient evidence that a pro-
longed conservative care strategy is effective. More insight
is needed into the potential short-term effects of a relative
early surgery strategy, as compared to an extended wait-
and-see period. In particular the effects on the return to
work or resumption of previous daily activities as well as
the complications of both strategies have not yet been
investigated.
The main goal of this comparative study is to investigate
whether the completion of a 6–12 weeks period of lasting
radicular pain constitutes a solid indication for surgery
and is superior to prolonged conservative care. A second-
ary goal is to identify possible subgroups of patients who
will substantially benefit from one of the proposed treat-
ment strategies. The cost-effectiveness results will be a
trade-off between a quicker relief of leg pain in the surgery
group versus the advantage of lower costs and avoiding
the negative effects of surgery in the conservatively treated
group. The difference in disease related quality of life
depends on the duration of persisting pain and disability
after randomization in the prolonged conservative care
group.
This study to investigate this scientific gap in our under-
standing of the effectiveness of surgery for LSRS is in line
with a recommendation by the Dutch Health Council in
1999 to the Minister of Health [4] and the current
Cochrane Review [15,16].
The results of this trial will lead to a more rational use of
the existing guidelines if the hypothesis is rejected. If the
latter is accepted and prolongation of the conservative
treatment policy is more cost-effective than surgery after
6–12 weeks, the current guidelines for the timing of sur-
gery need correction.
Methods/design
To answer the main research question the investigators
propose to conduct a multi-centre comparative rand-
omized clinical trial with parallel group design. The main
research question will be answered after a follow-up of six
months (Figure 1). The complete follow-up will last two
years. The multi-centre design is necessary to collect
enough patients in two years. The Medical Ethics Com-
mittee of all participating hospitals approved the study
protocol.
Patients
All patients between 18 and 65 years with sciatica of less
than 12 weeks duration are eligible for this study. Because
of the multi-centre (15 hospitals) design the patients in a
large region in the western part of the Netherlands can be
included in this trial if they meet the in- and exclusion cri-
teria (Table 1). Because these are the only hospitals, which
treat lumbar disc herniations in this area, included
patients will reflect a representative population treated in
primary and secondary care. Inclusion of patients will be
started after a visit to the neurological outpatient clinics.BMC Musculoskeletal Disorders 2005, 6:8 http://www.biomedcentral.com/1471-2474/6/8
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Flow chart of the Sciatica Trial Figure 1
Flow chart of the Sciatica Trial
GP Referral Patients with < 6-10 weeks LSRS 
Neurologist: Inclusion Criteria LSRS for Sciatica Trial 
Research Nurse: Baseline measurements and Informed Consent
Randomization 
Approval Neurosurgeon  
Clinical signs related to nerve root compression 
Surgery in 2 weeks  Conservative Care with possible 
late surgery 
Follow-up 2-year  Follow-up 2-year 
Main Follow-up visits at 8 
weeks, 6 months, and 1 year BMC Musculoskeletal Disorders 2005, 6:8 http://www.biomedcentral.com/1471-2474/6/8
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Randomization will start after at least 6 weeks persistent
disabling pain in the dermatome of the leg served by the
L4, L5 or S1 root. All 1100 GP's involved will be informed
about this study and receive information about develop-
ments and the results of the trial. They will refer patients
within the first 6–12 weeks after onset sciatica.
During the first visit to the neurological outpatient clinic
the patient's history will be taken and a standardized neu-
rological examination will be performed. During this visit
the neurologist will inform the patient on the cause and
course of a lumbosacral radicular syndrome and convey
the doubt regarding the timing of surgery for this condi-
tion. The study will be explained to the patient and in case
of a positive reaction an appointment is made to meet one
of the research nurses as soon as possible.
Preferably the study MRI scans will be performed after
informed consent during the first visit to the research
nurse. Because the patient needs some time to consider
participation a second visit will be planned at least two
days after the first visit to the outpatient clinic. The
research nurse will give all extra information needed to
understand the trial and will ask the patient if he/she
agrees to be randomized. Informed by the radiologist and
surgeon, the research nurse will only randomize the
patient during the third visit if the MRI confirms the pres-
ence of unilateral disc herniation and the patient is eligi-
ble according to the inclusion and exclusion criteria. The
patient will not be aware of detailed MRI data. The radiol-
ogist and neurosurgeon independently using a standard-
ized Case Record Form (CRF) will register the MRI
findings. The MRI will be performed according to a stand-
ardized protocol and including Gadolinium series for the
intended subgroup analysis.
Treatment allocation
Patients will randomly be allocated to either surgery
within 1–2 weeks or prolonged conservative treatment by
their GP. Patients, their doctors and research nurses can
obviously not be blinded for the allocated treatment.
Blinding of the outcome measurements is not possible,
due to the fact that mainly self-reported outcomes are
used. A randomization list is prepared for every participat-
ing hospital. Permuted blocks of random number patients
are formed to ensure near-equal distribution of patients
over the two randomization arms in the hospitals. Using
random number tables generates the random sequence of
the permuted blocks. The data manager, who is not
involved in the selection and allocation of patients will
prepare coded, sealed envelopes containing the treatment
allocation. During the second patient visit the research
nurse will open the envelope together with the patient
and appointments will be made for the allocated treat-
ment, either surgery or referral back to the GP, to ensure
that treatment is started as soon as possible after randomi-
zation. This will be done after checking all the criteria and
especially the persistence of pain with disability in daily
functioning. A letter about the allocated treatment arm
informs all caregivers. Although the principal investigator
will not include and operate upon trial patients he may be
biased with a preference for surgery, which could theoret-
ically influence analysis. Therefore the principal investiga-
tor is blinded for the allocated treatment. As he is not
involved in treatment of the study population blinding
during later analysis is only possible after blinding during
the randomization and follow-up period.
Interventions
After randomization two groups of patients will exist.
Group A; the surgically treated patients and group B; the
conservatively managed patients.
Surgical treatment
(A) will be performed in the conventional manner with
microscope or loupe magnification. The investigators pre-
fer the standard surgical approach because the other (min-
imally invasive) surgical approaches have limited
indications, are not more cost-effective, and have a long
learning curve. During the transflaval approach care is
undertaken to minimize bony removal and on the other
hand to prevent overstretching of the compromised nerve
root. In addition to removal of herniated disc material as
much as possible nuclear material will be removed with
pituitary forceps, curettes and rongeurs in order to prevent
recurrence. The participating treating doctors are 2 ortho-
paedic- and 12 neurosurgeons with large experience in the
Table 1: Selection criteria for trial eligibility
Inclusion criteria:
• Age 18–65 yr.
• Persistent radicular pain in the L4, L5 or S1 dermatome with or 
without mild neurological deficit
• Severe disabling leg pain of 6–12 weeks duration
• Evidence of a unilateral disc herniation confirmed on MRI
• Sufficient knowledge of Dutch language
• Informed consent
Exclusion criteria:
• Cauda equina syndrome or severe paresis (MRC<3)
• Complaints of a lumbosacral radicular syndrome in the same 
dermatome within the past 12 months
• A history of unilateral disc surgery on the same level
• Spinal canal stenosis
• Degenerative or lytic spondylolisthesis
• Pregnancy
• "Severe life-threatening" or psychiatric illness
• Planned (e)migration to another country in the year after 
randomizationBMC Musculoskeletal Disorders 2005, 6:8 http://www.biomedcentral.com/1471-2474/6/8
Page 6 of 11
(page number not for citation purposes)
standard approach with loupe magnification or micro-
scope. A standardized CRF will register the findings of the
surgeon and the herniated disc material will be investi-
gated histologically for granular infiltration.
Surgery will take place as soon as possible and within a
maximum of two weeks after randomization. Hospital
admission will be 2–7 days, including the day of surgery.
During the immediate post-operative period the patients
will be mobilised with the help of a physiotherapist. At
home guidance is confirmed by their own physiothera-
pist. The frequency will be 2 times a week for 8 weeks.
Conservative management
(B) will be conducted by the general practitioner (GP) or
neurologist when necessary. The GP will provide ample
information about the favourable prognosis of LSRS. The
treatment of LSRS is aimed primarily at pain relief and
maintenance/restoration of normal day-to-day activities.
Unfortunately, the effect of giving information and coun-
selling has not been studied specifically among LSRS
patients. However, various studies have evaluated the
effect of such support for people suffering from other pain
syndromes [24]. Inferences can reasonably be made from
the findings of these studies. Hence, it may be assumed
that adequate and unambiguous information about what
is wrong (the nature of the condition) and what the
patient can expect (the prognosis), together with trustwor-
thy counselling can reduce the anxiety and uncertainty felt
by the patients and thus ease the pain [12]. The GP's will
encourage the patients to continue with normal day-to-
day activities in so far as possible. When necessary analge-
sic medication can be prescribed according to the guide-
lines. The GP will advise the patients to stay active and if
possible return to work and/or their leisure activities.
After the first consultation the GP will make a follow-up
schedule. During the next visit the patient and doctor will
look at the changes since the first visit to determine
whether there is any improvement in the ability to per-
form normal activities. The doctor will check the efficacy
of the prescribed pain medication and may adjust the
dose or sort of analgesics according to the NHG guide-
lines. In these guidelines paracetamol is the first choice. If
not effective, NSAID's (ibuprofen, diclofenac or
naproxen) are to be prescribed. Only in the event of severe
disabling pain morphine may be given for a restricted
period of time. By preference all analgesics should be
taken at fixed times of the day rather than on a 'if neces-
sary' basis. If the GP and the patient conclude that there is
considerable kinesiophobia because of the fear that the
radicular or low back pain will increase, the help of a
physiotherapist can be recommended. Guided by the GP
(and physiotherapist) the patient will upgrade his or her
activities according to the agreed time schedule [25,26].
The guide will be time, not the intensity of the pain. The
GP will be free in her/his choice of prescription of medi-
cation and referral to physiotherapists. The research nurse
will register the conservative management strategy after
communication with the responsible GP. In case of pro-
gressive neurological deficit or worsening intolerable pain
the GP can refer the patient back to the research nurse or
neurosurgeon. If, six months after randomization, the
patient has still not improved or suffers from intermittent
LSRS, surgical treatment will be offered. Some patients
will ask for surgery earlier because of worsening drug
resistant leg pain. In these cases and in the case of a pro-
gressive neurological deficit, surgery will be performed in
consultation with the patient. If after maximum conserva-
tive treatment and counselling the patient is still not able
to cope with the functional disability surgery can be
requested. If surgery in these cases is not offered by the
study-group the patient does have the right to have a sec-
ond opinion with an undependable neurosurgeon of
another university hospital.
Outcome assessment
In the LSRS the most common complaints are pain and
disability to perform normal daily activities. We will use
below described validated outcome parameters, which
will be assessed by means of questionnaires. Patients are
not informed about their earlier scores. Follow-up exami-
nations by the research nurse will take place 8, 26 and 52
weeks after randomization and the patients will keep a
diary (table 2). In between at 2, 4, 12, 38, and 78 and after
104 weeks the main questionnaire (primary outcome
measures) will be filled in at home and send to the data
centre.
Primary outcome measures
1) Roland Disability Questionnaire for Sciatica.' This ill-
ness-specific 23-item functional assessment questionnaire
is frequently used for low back pain and sciatica [38,39].
Scores range from 0 to 23, reflecting a simple unweighted
sums of items endorsed by the respondent. Patients with
high scores at baseline do have a severe disabling LSRS. To
define recovery a difference of at least 11 points from
baseline has to be seen [38,17]. The Roland Question-
naire for Sciatica has a documented high level of internal
consistency; construct validity, and responsiveness
[38,39]. It is the main primary outcome measure in this
trial.
2) Perceived recovery.' This is a seven-point Likert scale
measuring the perceived recovery, varying from 'com-
pletely recovered' to 'worse than ever'. This outcome scale
has been used in previous studies and appears to be valid
and responsive to change [27]. Next to this global self-
assessment a job and hobby specific Likert will be scored.
During the intake of the study the patient will be asked toBMC Musculoskeletal Disorders 2005, 6:8 http://www.biomedcentral.com/1471-2474/6/8
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rank their five most important functional disabilities in
daily live (work, hobby), which they can use in their own
evaluation overall and in separate items.
3) VAS pain in the leg. This parameter will measure the
experienced intensity of pain in the leg during the week
before visiting the research nurse. Pain will be assessed on
a horizontal 100 mm scale varying from 0 mm, 'no pain
in the leg', to 100 mm, 'the worst pain ever'. Patients do
not see the results of earlier assessments and will score the
pain experienced at the visit. [28-32].
Secondary outcome measures
1) EuroQol classification system and VAS rating personal
health. A cost-utility analysis will be performed using
QALY's based on the EuroQol questionnaire, which has
been validated in many studies and is easy to fill out
[41,42,51]. The EuroQol will be measured twice a week
during the first four weeks and at all follow-up moments.
Patients describe their general health status using the
EuroQol classification system, consisting of 5 questions
on mobility, self care, usual activities, pain/discomfort,
and anxiety/depression [44]. From the EQ-5D classifica-
tion system, the EQ-5D utility index will be calculated
[43]. This utility measure reflects how the general public
values the health status described by the patient, which is
preferred for economic evaluations from a societal per-
spective. Patients also rated their personal health using a
visual analog scale (VAS) ranging from worst imaginable
health to best imaginable health.
2) Short-Form 36 (SF-36). Quality of life was also assessed
using the RAND-36 questionnaire. This is a generic health
status questionnaire, which can easily be filled out at
home. The questionnaire consists of 36 items on physical
and social functioning has 8 domains; 1) physical func-
tioning, 2) physical restrictions, 3) emotional restrictions,
4) social functioning, 5) somatic pain, 6) general mental
health, 7) vitality, 8) general health perception. This ques-
tionnaire has been used frequently and was validated in
studies on low back pathology and surgery [33-37]. From
the RAND-36, the SF-6D utility index was calculated. Like
the EQ-5D, this SF-6D reflects the general public's valua-
tion of the health described by the patient. The SF-6D is a
recent instrument that has not been used much yet, but it
richer classification system could make it a more sensitive
utility measure than the EuroQol measure.
3) Sciatica Frequency and Bothersome Index (SFBI). This
is a scale from 0 to 6, which can assess the frequency (0 =
not at all to 6 = always) and bothersomeness (0 = not
bothersome to 6 = extreme bothersome) of back and leg
symptoms. The sum of the results of four symptom ques-
tions yields both indexes, ranging from 0 to 24: leg pain;
numbness and/or tingling in the leg; weakness in the leg
or foot; pain in the back or leg while sitting. [17].
5) PROLO-scale. This scale measures the evaluation of the
research nurse of the functional-economic status of the
patients. This parameter has been used in studies on the
difference in functional outcome between different tech-
niques of lumbar spine fusion [40].
6) VAS pain in the back. This parameter measures the
intensity of the pain in the back experienced during the
week before visiting the research nurse. Assessment will be
based on a horizontal 100 mm scale varying from 0 mm,
'no pain in the back', to 100 mm, 'the worst pain ever'.
Patients do not see the results of earlier assessments and
will score their pain during the visit. This parameter is
included because a lot of patients with LSRS also have
back pain in varying intensities, which can change after
surgery or conservative treatment.
Table 2: Data collection and outcome measures
Time in weeks ? 0 2,4 8 12 26 38 52 78 104
Likert X XXX XXXXX X
Neurological examination XX XX
Severity of complaints (VAS) X XXX XXXXX X
McGill X
Health Status (SF 36) XX X X X
Functional Status (RDQ) X XXX XXXXX X
EuroQol/VAS Q-of-life X XXX XXXXX X
MRI XX
Costs X XXX XXXXX X
Prolo XX X X
Complications XX XX
Surgery XX X X X
SFBI XX X X X XBMC Musculoskeletal Disorders 2005, 6:8 http://www.biomedcentral.com/1471-2474/6/8
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Other outcome measures
1) Costs. The societal costs during the first year will be
estimated in accordance with the recent pharmacoeco-
nomic guideline [47,48]. The costs of hospital admission
and surgery will be based on an integral top-down cost
analysis in three large regional participating hospitals
(aggregated according to the total number of patients per
department). From this institutional analysis, the con-
stant costs per admission and the variable costs per admis-
sion day will be estimated. From these constant and
variable costs, the individual costs of hospital admission
and surgery for all patients can be estimated, using the
duration of the hospitalization. In the study an MRI is per-
formed in all cases. The costs of this MRI will only be cal-
culated for patients undergoing surgery, because in the
normal situation MRI would only be performed when a
surgical indication exists.
Patients will register other health care needs in a diary
(including physiotherapy, visits to GP's and specialists,
nursing care and medication). Each diary covers a period
of 3 months and will be discussed with the patient during
the follow-up visits to the research nurse. The volume of
health care will be assessed using standard prices [48].
In the diary the patient will also register direct non-medi-
cal costs (including time costs, travel expenses and domes-
tic help). To estimate productivity costs the patients will
also report absenteeism in the diary. At the follow-up vis-
its, the research nurse will register the work situation,
work efficiency and gross wages. Absenteeism will be val-
ued according to the friction-cost method.
2) Incidence of (re-) surgery. One of the goals of the policy
for group B is to avoid surgery while achieving at least the
same effects. The surgical rate is therefore an indication of
the success or failure of this policy. The incidence of re-
operation at the same disc level in group A will be an indi-
cation of the failure rate for surgery.
3) Side-effects or complications that are ascribed to the
treatment are recorded by the patients, their treating phy-
sicians and the research nurses.
4) MRI findings. The results of the differences between the
baseline MRI and the MRI made 52 weeks after randomi-
zation are important secondary outcome measures. The
difference in size of the disc herniation (in mm), nerve
root compression, and amount of scar tissue will be regis-
tered. Failures of surgery can be recognized by inadequate
disc removal or decompression of the nerve. The data will
be gathered, using a standardized CRF, which will be filled
out by the local radiologist, orthopaedic- or neurosurgeon
and (neuro-) radiologist
Sample size
The result of this study is based on the short-term success
of surgical intervention and will be a trade-off between a
quicker relief of leg pain versus an advantage in cost-effec-
tiveness for conservatively managed patients. The sample
size is calculated on the basis of the Roland Disability
Questionnaire for Sciatica averaged during the 12 months
follow-up period. The numbers used for this sample-size
are drawn from the Maine Lumbar Spine Study 1 year and
recently published 5-year results [19,55]. The difference in
the Roland score between the surgical- and non-surgical
group in this study did not change between 3 and 12
months follow-up as shown in their study [19] and can be
averaged over the first year. The main aim of this study is
to measure the short-term functional difference at 12
months follow-up. Surgical treatment is considered better
when the post treatment change is at least 4 points more
when compared to the conservative treatment arm [38]
and constant over time. Considering this constant differ-
ence and a mean standard deviation =10 over the first year
[55] 140 patients per treatment arm are needed to reach a
power (1-β) of 0,90 with α = 0.05 (two-sided). To answer
the main research question 280 patients are needed for
analysis with at least 12 months follow-up. The aim is to
enrol 300 (150 per arm) patients in the study, including 8
% loss to follow-up after 1 year. The total number of oper-
ated patients each year in all participating hospitals
exceeds 1400. With this number of patients also a clini-
cally important difference in median time to recovery of
two months can be detected by survival analysis.
Although the time to recovery is the main issue, the prob-
lem of recurrent complaints is still not solved in the differ-
ent approaches of survival and proportional hazard
analysis.
Statistical and cost analysis
Baseline comparability will be investigated by descriptive
statistics to examine if randomisation was successful. Dif-
ferences in success rates between both groups are calcu-
lated, together with 95 per cent confidence intervals. In
addition to an analysis of the difference in recovery
between the two groups (as explained under the para-
graph sample size) analyses of the difference in time to
recovery will be carried out. Due to lack of data in the lit-
erature we could not base our sample size calculations on
these differences. Survival-analysis is used to calculate dif-
ferences in median time to recovery. Continuous out-
comes are evaluated as change scores (differences between
baseline measurement and each follow-up measure-
ment). Multivariable analyses are performed to adjust for
the eventual differences between the groups at baseline in
prognostic indicators. All the analyses are performed
according to the intent-to-treat principle. An additional
per protocol analysis is performed comparing patients in
the wait-and-see group who received surgery with patientsBMC Musculoskeletal Disorders 2005, 6:8 http://www.biomedcentral.com/1471-2474/6/8
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in the same group who had not and with patients in the
surgery group. To compare the actual treatment sec
instead of strategies an explorative analysis will be per-
formed in subgroups off all patients who actually received
surgery and who did not receive surgery in both groups.
All patients who withdraw from the study are included in
the analysis until the time of withdrawal.
The result of this study will be a trade off between the dis-
advantages of surgery (hospitalisation, reduced quality of
life and costs) versus the possible advantages (earlier relief
of pain and return to work). For that reason recovery,
measured as an 11 point difference in score when com-
pared to baseline (Roland Disability Questionnaire for
Sciatica), is the clinically most relevant patient outcome.
Quality of Life (SF-36) and perceived recovery are impor-
tant to compare the reduced quality of life from surgery to
the possibly prolonged pain from conservative therapy
and also to be able to compare cost-effectiveness with that
of other spine interventions. The EuroQol is important to
obtain cost-utility ratio's that can be compared with those
of a wide range of other interventions. Utilities are
obtained from the descriptive classification system of the
EuroQol, using the model described by Dolan [43,53].
Conservative treatment may decrease costs compared to
surgery but possibly at the expense of delayed effective-
ness. In an incremental cost-effectiveness analysis, societal
costs during the first year will be compared to the primary
outcome measure (Roland Disability Questionnaire for
Sciatica, averaged over the first year), Quality of Life (SF-
36, during the first year) and perceived recovery (7-points
Likert scale). Cost-effectiveness analyses with these effec-
tiveness measures have been conducted before, allowing
comparison with other spine interventions.
Finally, to answer the second research question explora-
tive analyses are conducted to investigate whether the
treatment effect after two, six and twelve months varies in
specific subgroups of patients (Table 3).
Using logistic regression for success rate and linear regres-
sion for severity of the disability, each prognostic indica-
tor is checked for interaction with treatment. If the
interaction term is significant, a stratified analysis will be
performed.
Discussion
In this article the rationale and design of a pragmatic RCT
on the cost-effectiveness of timing of disc surgery for LSRS
is described. The only randomized trial [7] so far on this
subject only included patients where the caregiver was in
doubt about the surgical indication. Patients with severe
disabling pain were not randomized [8]. The Sciatica Trial
is directed to those patients with a clear surgical indication
according to current usual care. The study is pragmatic
because it acknowledges that sometimes it may not be
possible to postpone surgery for every conservative care
patient until 6 months after allocation and that some
patients will recover before surgery is performed in the
surgical group. In these cases we consider it unethical to
hold on to the randomized treatment. Because of the
Intent-to-Treat analysis these cases will be analysed in
their own allocated randomization arm and will not cause
methodological problems because it is two healthcare
strategies that are compared, as opposed to two treat-
ments. The objective of this trial is to provide evidence on
the preferred timing of disc surgery for sciatica. A pro-
longed conservative treatment strategy is compared to the
international guideline advise of surgery after 6–8 weeks
LSRS. The intended size of the study population is suffi-
ciently large to detect short and long term differences
between both strategies.
Abbreviations
GP = General Practitioner
LSRS = Lumbosacral Radicular Syndrome
RCT = Randomized Controlled Trial
VAS = Visual Analogue Scale
Table 3: Selected prognostic variables for subgroup analysis
Demographic Variables
• Age < 39 years versus > 39 years,
• Intellectual versus physical demanding job,
Anamnestic and Neurological Variables
• Acute start LSRS versus slow start,
• History of backpain versus no history,
• Influence of coughing, sneezing on complaints versus no influence,
• Difficulty to put on shoes and/or socks versus no difficulty,
• Straight leg raising ≤ 30 degrees versus > 30 degrees,
• Positive crossed straight leg raising sign versus negative sign,
• VAS-pain > 70 versus < 69 mm,
• Tingling/numbness in pain area versus no tingling (9),
• Pain leg worse by sitting versus no worsening (9),
• McGill affective high score versus low score,
Radiological Variables
• MRI disc sequester versus contained disc herniation,
• MRI circumferential gadolinium enhancement versus no 
enhancement of disc herniation,
• Mediolateral versus median and lateral disc herniation,
• High versus low height of disc level (height 9 mm),
Miscellaneous Variables
• Preference for surgery versus no preference for surgery.
• Disc Herniation at L5S1 vs. L4L5BMC Musculoskeletal Disorders 2005, 6:8 http://www.biomedcentral.com/1471-2474/6/8
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